Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The reductions were dose-dependent: 4.9% with the 0.5mg dose, 15.2% with 4mg, 26.1% with 8mg, and 23.2% with 12mg
Combination therapy produces greater weight loss All treatment groups had improvements in fasting glucose, mean glucose, insulin sensitivity and insulin secretion at 24 weeks
Sleep deprivation and chronic stress can blunt appetite suppression, making lifestyle factors equally important as medication adherence
Is there something more effective
While many studies evaluating cognitive effects have relatively short follow-up periods, one observational study with a control group found that cataract surgery slowed the rate of cognitive decline over a period of more than 10 years as measured using a test of episodic memory (Maharani et al., 2018)
Tirzepatide (15 mg weekly) drives 15.7% weight loss over 72 weeks in patients with obesity and T2D (45) and 22.5% weight loss in patients with obesity alone (46)
